ビスモデギブ
ビスモデギブ 物理性質
- 融点 :
- 179-181°C
- 沸点 :
- 561.6±50.0 °C(Predicted)
- 比重(密度) :
- 1.440
- 貯蔵温度 :
- -20°
- 溶解性:
- DMSO (最大 200mg/ml) またはエタノール (加熱すると最大 10mg/ml) に可溶
- 外見 :
- 白い固体。
- 酸解離定数(Pka):
- 10.72±0.70(Predicted)
- 色:
- オフホワイトまたはベージュ
- 安定性::
- DMSO溶液またはエタノール溶液で-20°Cで最大3か月保存できます。
ビスモデギブ 価格
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
ビスモデギブ 化学特性,用途語,生産方法
効能
抗悪性腫瘍薬, スムーズンド阻害薬
説明
In January 2012, the US FDA approved vismodegib (also referred to as
GDC-0449) for the treatment of adults with metastatic basal cell carcinoma
(BCC), with locally advanced BCC that has recurred following surgery or
who are not candidates for surgery or radiation. Vismodegib inhibits the Hh sig?naling pathway by functioning as an antagonist of SMO thereby inhibiting the activation of Hedgehog target genes, resulting in decreased downstream pro?duction of proliferation factors. The IC
50 of vismodegib in a Hedgehog?responsive cell line derived from human embryonic palatal mesenchyme cells was 2.8 nM. In preclinical in vivostudies, vismodegib at 12.5 mg/kg (bid) caused complete regression of tumors in a Hh pathway dependent medulloblas?tomaallograft model generated from Ptch+/-mice. A synthesis of vismodegib starting from 2-chloro-5-nitro aniline and employing a Negishi coupling with 2-pyridyl zinc iodide as a key step has been reported.
化学的特性
White Solid
定義
ChEBI: A benzamide obtained by formal condensation between the carboxy group of 2-chloro-4-(methylsulfonyl)benzoic acid and the anilino group of 4-chloro-3-(pyridin-2-yl)aniline. Used for the treatment metastatic basal cell carcinoma.
ビスモデギブ 上流と下流の製品情報
原材料
準備製品
ビスモデギブ 生産企業
Global( 235)Suppliers
879085-55-9(ビスモデギブ)キーワード:
- 879085-55-9
- 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide
- VisModegib (GDC-0449)
- BenzaMide, 2-chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(Methylsulfonyl)-
- GDC-0449,Vismodegib
- 2-Chloro-N-(4-chloro-3-(pyridin-2-yl)-phenyl)-4-(methylsulfonyl)benzamide
- VisModegib Base
- 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide Vismodegib(GDC0449)
- Vismodegib 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide
- Vismodegib, >=99%
- VISMODEGIB (GDC-0449);GDC0449
- 101098
- CS-1913
- Vismodegib, 98%, a Hedgehog inhibitor
- GDC04499(Vismodegib)
- GDC-0449;GDC 0449;GDC0449
- RG 3616
- 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide USP/EP/BP
- 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfon...
- 2-Chloro-N-(4-chloro-3-(pyridine-2-yl)phenyl)-4-(methylsulfonyl)benzamide
- Vismodegib 13C7
- TIANFU-CHEM Vismodegib (GDC-0449)
- Erivedge
- GDC-0449
- Vismodegib
- 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide
- Xanthophyll Impurity 3
- Vimodji
- ビスモデギブ
- GDC-0449
- N-(3-(2-ピリジル)-4-クロロフェニル)-2-クロロ-4-(メチルスルホニル)ベンズアミド
- 2-クロロ-N-[4-クロロ-3-(ピリジン-2-イル)フェニル]-4-メタンスルホニルベンズアミド
- 2-クロロ-N-[4-クロロ-3-(2-ピリジル)フェニル]-4-(メチルスルホニル)ベンズアミド